Valuation: Cryo-Cell International, Inc.

Market Cap 27.9M 24.5M 22.79M 20.91M 39.29M 2.69B 39.89M 271M 106M 1.32B 105M 102M 4.57B P/E 2026 *
43.3x
P/E 2027 * 346x
Enterprise Value 27.9M 24.5M 22.79M 20.91M 39.29M 2.69B 39.89M 271M 106M 1.32B 105M 102M 4.57B EV / Sales 2026 *
0.93x
EV / Sales 2027 * 0.98x
Free-Float
31.4%
Yield 2026 *
-
Yield 2027 * -
1 day-1.14%
Current month+8.46%
1 month-8.95%
3 months-5.72%
6 months+1.47%
Current year+0.58%
1 week 3.3
Extreme 3.3
3.87
1 month 2.9
Extreme 2.9
3.87
Current year 2.72
Extreme 2.72
4.14
1 year 2.72
Extreme 2.72
5.43
3 years 2.72
Extreme 2.72
9.5
5 years 2.69
Extreme 2.69
14.16
10 years 0
Extreme 0
14.16
Manager TitleAgeSince
Chief Executive Officer 63 2011-07-31
Chief Executive Officer 64 2011-07-31
Director of Finance/CFO 57 1998-04-30
Director TitleAgeSince
Chairman 64 2011-07-31
Director/Board Member 63 2021-09-19
Director/Board Member 63 2011-08-24
Date Insider Type Main position Quantity % Market Cap.
5/28/26 Fiscal year

Chief Financial Officer

15,000 0.1862%
1/7/26 Other

Chief Technology Officer

30,000 0.3724%
1/7/26 Other

Chief Financial Officer

30,000 0.3724%
Change 5-day change 1-year change 3-year change Capi.($)
-1.14%0.00%-28.22%-41.06% 28.22M
+0.80%+0.25%+83.39%+41.86% 136B
+1.51%+2.97%+11.92%+34.02% 83.52B
+2.22%+4.96%+3.79%+56.43% 27.44B
-0.02%+8.15%+32.55%+58.21% 25.23B
+1.32%0.00%-14.44%-27.43% 20.05B
+17.17%+19.64%+57.16%+203.29% 17.14B
+0.50%-0.65%+62.63%+130.60% 15.04B
-0.86%-6.71%+2.39%-7.05% 14.55B
+0.65%+2.44%-5.50%-10.95% 12.98B
Average +2.22%+3.07%+20.57%+43.79% 35.24B
Weighted average by Cap. +1.76%+2.54%+42.25%+46.03%

Financials

2026 *2027 *
Net sales 30.04M 26.39M 24.54M 22.52M 42.31M 2.89B 42.96M 291M 114M 1.42B 113M 110M 4.92B 28.41M 24.96M 23.21M 21.3M 40.01M 2.74B 40.63M 276M 108M 1.35B 107M 104M 4.65B
Net income 634K 557K 518K 475K 893K 61.05M 907K 6.15M 2.4M 30.02M 2.38M 2.33M 104M 45K 39.52K 36.76K 33.73K 63.37K 4.33M 64.35K 436K 171K 2.13M 169K 165K 7.37M
Net Debt - -
Logo Cryo-Cell International, Inc.
Cryo-Cell International, Inc. is a cord blood banking company. The Company operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The Company stores approximately 240,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The Company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
Employees
74
Date Price Change Volume
26-07-24 US$3.460 -1.14% 3,001
26-07-23 US$3.500 -1.13% 3,462
26-07-22 US$3.540 +1.14% 29,942
26-07-21 US$3.500 +1.51% 12,559
26-07-20 US$3.448 -0.35% 1,700
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
3.460
Average target price
-

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CCEL Stock